- 28 February 2022
- Patient action plans
Action plan: Low-dose methotrexate for Crohn's disease/METHOTREXATE LIỀU THẤP TRỊ BỆNH CROHN (Vietnamese / Tiếng Việt)
- 28 February 2022
- Patient action plans
The Australian Commission on Safety and Quality in Health Care (the Commission) has completed its review of the NPS MedicineWise website and associated digital assets. Several key programs have already transitioned to the Commission including QUM Learning, MedicineInsight, Practice Reflections and the National Medicines Symposium. In addition, the Commission will soon be launching a new website that will include Medicine Finder and select QUM resources. All remaining resources on the NPS website will be archived and the website will be decommissioned in early May 2026. For more information, please email medsafety@safetyandquality.gov.au.
Please be aware that some content on this website may be outdated and not reflect current evidence or guidance.
We have many resources available for consumers and health professionals including brochures, fact sheets and translated resources. All of our products are available free of charge.
Annual reports, budgets, corporate plans, reports
Fact sheets, action plans, brochures, guidelines, and more for health professionals and consumers
Videos, podcasts, conference recordings, images and Infographics
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Prof Sarah Hilmer and Prof Josh Davis, members of the National COVID-19 Clinical Evidence Taskforce Guidelines Leadership Group. They give an update on the new antiviral treatments now available and answer some frequently asked COVID management questions.
Further reading
NPS MedicineWise www.nps.org.au/coronavirus/faqs-covid-19-antivirals-in-racfs
National COVID-19 Clinical Evidence Taskforce www.covid19evidence.net.au
Liverpool University Drug Interaction www.hiv-druginteractions.org/checker
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks to Dr Kate Annear, NPS MedicineWise medical advisor and Associate Professor Charlotte Hespe, GP, head of General Practice at Notre Dame University, and chair of the New South Wales ACT Faculty of the RACGP discuss the new oral antiviral COVID medications that have been provisionally approved for use.
Further reading
NPS MedicineWise https://www.nps.org.au/coronavirus/faqs-covid-19-antivirals-in-racfs
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Dr Karen Price, RACGP President on how being involved with shared decision-making can make a difference.
Further reading
Choosing Wisely: https://www.choosingwisely.org.au/resources/consumers-and-carers/5questions
Choosing Wisely: https://www.choosingwisely.org.au/translated-resources